Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Current Medical Research and Opinion
|
December 3, 2014
Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil
Edward Kim, Allen Seftel, Evan Goldfischer, et al.
Urology Practice
|
May 8, 2023
Reply by Authors
Robert A Dowling, Qingxia Chen, Evan Goldfischer, et al.
Urology Practice
|
April 27, 2023
Surgical Stone Treatment: Patterns May Predict Performance on Episode-based Cost Measure in the Quality Payment Program
Robert A Dowling, Qingxia Chen, Evan Goldfischer, et al.
Urology Practice
|
February 7, 2024
Telemedicine Utilization in the COVID-19 Era: Patterns of Care in Community Urology Practice
Robert A Dowling, Song Zhang, Evan Goldfischer, et al.
The Journal of Urology
|
November 16, 2010
Onset of efficacy of tadalafil once daily in men with erectile dysfunction: a randomized, double-blind, placebo controlled trial
Allen Seftel, Evan Goldfischer, Edward D Kim, et al.
The Journal of Sexual Medicine
|
February 29, 2008
Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States
Ira D Sharlip, Bryan P Shumaker, Lawrence S Hakim, et al.
Urology
|
February 21, 2012
Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial
Evan Goldfischer, John J Kowalczyk, William R Clark, et al.
Journal of Sex & Marital Therapy
|
December 21, 2012
Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder
Anita H Clayton, Evan Goldfischer, Irwin Goldstein, et al.
Urology
|
January 7, 2019
A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility
Scott Eggener, Lawrence I Karsh, Tim Richardson, et al.
Urology
|
April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort
Gregg Eure, Raymond Germany, Robert Given, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Current Medical Research and Opinion
|
December 3, 2014
Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil
Edward Kim, Allen Seftel, Evan Goldfischer, et al.
Urology Practice
|
May 8, 2023
Reply by Authors
Robert A Dowling, Qingxia Chen, Evan Goldfischer, et al.
Urology Practice
|
April 27, 2023
Surgical Stone Treatment: Patterns May Predict Performance on Episode-based Cost Measure in the Quality Payment Program
Robert A Dowling, Qingxia Chen, Evan Goldfischer, et al.
Urology Practice
|
February 7, 2024
Telemedicine Utilization in the COVID-19 Era: Patterns of Care in Community Urology Practice
Robert A Dowling, Song Zhang, Evan Goldfischer, et al.
The Journal of Urology
|
November 16, 2010
Onset of efficacy of tadalafil once daily in men with erectile dysfunction: a randomized, double-blind, placebo controlled trial
Allen Seftel, Evan Goldfischer, Edward D Kim, et al.
The Journal of Sexual Medicine
|
February 29, 2008
Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States
Ira D Sharlip, Bryan P Shumaker, Lawrence S Hakim, et al.
Urology
|
February 21, 2012
Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial
Evan Goldfischer, John J Kowalczyk, William R Clark, et al.
Journal of Sex & Marital Therapy
|
December 21, 2012
Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder
Anita H Clayton, Evan Goldfischer, Irwin Goldstein, et al.
Urology
|
January 7, 2019
A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility
Scott Eggener, Lawrence I Karsh, Tim Richardson, et al.
Urology
|
April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort
Gregg Eure, Raymond Germany, Robert Given, et al.
Page
of 2